Ti Jun Yu
Direttore/Membro del Consiglio presso Shanghai Mingyuan Enterprise Group Co. Ltd.
Posizioni attive di Ti Jun Yu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shanghai Mingyuan Enterprise Group Co. Ltd. | Direttore/Membro del Consiglio | 19/03/2010 | - |
Corporate Officer/Principal | 19/03/2010 | - | |
China Association of Health Education | Direttore/Membro del Consiglio | 19/03/2010 | - |
Corporate Officer/Principal | 15/09/2011 | - | |
Eastern China Health Education Research Society | Direttore/Membro del Consiglio | 19/03/2010 | - |
Shanghai Corporate Health Management Promotion Committee | Corporate Officer/Principal | - | - |
Storia della carriera di Ti Jun Yu
Precedenti posizioni note di Ti Jun Yu
Società | Posizione | Inizio | Fine |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Direttore/Membro del Consiglio | 30/06/2004 | 20/05/2016 |
Statistiche
Distribuzione geografica
Cina | 5 |
Hong Kong | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
Shanghai Mingyuan Enterprise Group Co. Ltd. | |
China Association of Health Education | |
Eastern China Health Education Research Society | |
Shanghai Corporate Health Management Promotion Committee |
- Borsa valori
- Insiders
- Ti Jun Yu
- Esperienza